Inactive Instrument
Company Cognetivity Neurosciences Ltd. Canadian Securities Exchange
Stocks
CGN
CA19243C1005
Advanced Medical Equipment & Technology
Business description: Cognetivity Neurosciences Ltd.
Sales by Activity: Cognetivity Neurosciences Ltd.
| Fiscal Period: January | 2019 (CAD) | 2020 (CAD) | 2021 (CAD) | 2022 (CAD) | 2023 (CAD) |
|---|---|---|---|---|---|
Development of The ICA Platform | - | - | - | - | 45.37K |
Geographical breakdown of sales: Cognetivity Neurosciences Ltd.
| Fiscal Period: January | 2019 (CAD) | 2020 (CAD) | 2021 (CAD) | 2022 (CAD) | 2023 (CAD) |
|---|---|---|---|---|---|
United Kingdom | - | - | - | - | 45.37K |
Executive Committee: Cognetivity Neurosciences Ltd.
| Manager | Title | Age | Since |
|---|---|---|---|
Sina Habibi
CEO | Chief Executive Officer | 45 | 01/04/2013 |
Mark Phillips
CMP | Compliance Officer | 67 | 21/12/2017 |
Composition of the Board of Directors: Cognetivity Neurosciences Ltd.
| Director | Title | Age | Since |
|---|---|---|---|
Sina Habibi
BRD | Director/Board Member | 45 | 01/01/2017 |
Mark Phillips
BRD | Director/Board Member | 67 | 21/12/2017 |
Company details: Cognetivity Neurosciences Ltd.
Medical Software & Technology Services
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.22% | -5.44% | -45.07% | -22.59% | 25.15B | |
| -0.76% | +2.96% | -39.44% | +144.72% | 12.47B | |
| -1.27% | -7.81% | -12.00% | +49.30% | 5.82B | |
| +2.46% | +11.59% | - | - | 2.83B | |
| -3.51% | +0.84% | +35.14% | -46.30% | 1.75B | |
| +3.74% | +5.40% | - | - | 1.78B | |
| +2.47% | +4.10% | -28.61% | - | 1.28B | |
| -2.53% | -4.93% | -36.10% | -60.48% | 795M | |
| -1.66% | -4.22% | -33.74% | +213.02% | 767M | |
| Average | -0.73% | +0.11% | -22.83% | +46.28% | 5.85B | |
| Weighted average by Cap. | -2.68% | -1.83% | -35.91% | +33.32% |
